Eucrisa OverviewCrisaborole (trade name Eucrisa) is a nonsteroidal topical medication approved for the treatment of mild-to-moderate atopic dermatitis (eczema) in patients 2 years of age and older. As of 2016[update] it is also under development by Anacor Pharmaceuticals for the topical treatment of psoriasis. Contents 1 Mechanism of action 2 Chemistry 3 Clinical trials 4 See also 5 References Mechanism of action It is a phosphodiesterase-4 inhibitor, mainly acting on phosphodie...
Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Crisaborole
Recent Eucrisa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 2%
NDC Database Records for Eucrisa: (1 result)Sorted by National Drug Code
- 55724-211 Eucrisa 20 mg/g Topical Ointment by Anacor Pharmaceuticals, Inc.